Lenva Capsules contain lenvatinib, an oral anticancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. Lenva is prescribed by qualified healthcare professionals for the treatment of certain cancers, depending on the patient's diagnosis, treatment history, and overall medical condition. Cordium Pharmaceuticals Pvt Ltd supplies pharmaceutical products in India and supports access to prescription medicines through appropriate healthcare and pharmaceutical channels. Lenva Capsules Product Description Lenva contains lenvatinib, which works by inhibiting specific kinase pathways involved in tumour growth and the formation of blood vessels that can support tumour development. The medicine is used in specific cancer treatment settings under the supervision of an oncologist or other qualified healthcare professional. Lenvatinib is used for certain patients with differentiated thyroid cancer and may also be used in particular treatment combinations for renal cell carcinoma, hepatocellular carcinoma, and endometrial carcinoma, depending on the approved indication and treatment protocol. Lenva should only be taken according to the prescription provided by a doctor. The appropriate dose can differ according to the type of cancer, other medicines being used, and factors such as kidney or liver function. Patients should not change the dose or discontinue treatment without medical advice. Lenva Capsules Strengths Lenva Capsules are available in the following strengths: Lenva 4 mg Capsules – Lenvatinib Lenva 10 mg Capsules – Lenvatinib The 4 mg and 10 mg strengths are documented for lenvatinib capsule formulations in India. The required strength and dosing schedule should be determined by the treating physician. Depending on the patient's response and tolerability, a healthcare professional may modify the treatment regimen. Lenva Capsules: Important Safety Information Lenvatinib is a potent prescription anticancer medicine and requires appropriate medical monitoring. Possible adverse effects may include high blood pressure, diarrhoea, decreased appetite, fatigue, nausea, vomiting, weight loss, protein in the urine, mouth sores, headache, and changes in voice. More serious risks can include hypertension, liver problems, kidney impairment, bleeding, cardiac complications, proteinuria, and other clinically significant reactions. Patients should inform their doctor about existing medical conditions and all medicines or supplements they are taking before starting treatment. Frequently Asked Questions About Lenva Capsules 1. What is Lenva Capsule used for? Lenva contains lenvatinib and is prescribed for certain types of cancer, including specific cases of differentiated thyroid cancer and other cancers according to the applicable treatment indication. 2. What are the available Lenva strengths? Lenva is available in 4 mg and 10 mg capsules. Your doctor will decide which strength is appropriate for your treatment. 3. Is Lenva a prescription medicine? Yes. Lenva is an anticancer prescription medicine and should be used only under the supervision of a qualified healthcare professional. 4. Can I change my Lenva dose myself? No. Lenvatinib dosing can depend on the cancer being treated and individual patient factors. Dose adjustments should only be made by the treating doctor. 5. What should I do if I experience side effects? Contact your treating healthcare professional if side effects occur, particularly if symptoms are severe, persistent, or unusual. Do not stop cancer treatment without medical advice. 6. Where can I enquire about Lenva Capsules in India? For pharmaceutical supply enquiries, buyers and healthcare organisations can contact Cordium Pharmaceuticals Pvt Ltd for product availability, strength, documentation, and quotation information, subject to applicable prescription and regulatory requirements. Disclaimer: This page is for general product information and does not replace professional medical advice. Lenva Capsules should be used only on the advice and prescription of a qualified healthcare professional. Availability and supply are subject to applicable Indian laws and regulations.

INBEC Tablets Product Description INBEC Tablets are a prescription antiretroviral medicine used in the management of HIV-1 infection. Each tablet contains Abacavir 600 mg, Dolutegravir 50 mg, and Lamivudine 300 mg. This fixed-dose combination brings three antiretroviral medicines together in one tablet and is prescribed according to an individual's HIV treatment plan. INBEC works by targeting different stages of HIV replication. Abacavir and Lamivudine belong to the nucleoside reverse transcriptase inhibitor group, while Dolutegravir is an integrase inhibitor. Together, these medicines help reduce HIV replication and lower the amount of virus in the blood when used as prescribed. INBEC Tablets are generally used for eligible adults and adolescents weighing at least 40 kg, subject to medical assessment. A healthcare professional should determine whether this fixed-dose combination is appropriate for the patient. For people searching for INBEC Tablets online in India, Cordium Pharmaceuticals Pvt Ltd can provide product-related information and supply assistance, subject to prescription requirements and applicable pharmaceutical regulations. Buyers should obtain prescription medicines only through appropriate legal and licensed channels. How INBEC Tablets Work The three active ingredients in INBEC act against HIV through complementary mechanisms. Abacavir and Lamivudine interfere with reverse transcriptase, an enzyme required for viral replication. Dolutegravir blocks HIV integrase, another enzyme needed for the virus to reproduce inside cells. Consistent use of prescribed antiretroviral therapy can help control HIV and support immune-system function. INBEC is not a cure for HIV or AIDS, and treatment should be continued exactly as directed by a qualified healthcare professional. Important Safety Information INBEC should be taken only according to medical advice. Patients should inform their healthcare provider about existing liver or kidney problems, other medicines or supplements they use, and any previous reaction to antiretroviral medicines. Abacavir-containing treatment requires appropriate medical screening because serious hypersensitivity reactions can occur in susceptible individuals. Do not start, stop, or change HIV treatment without consulting your doctor. INBEC Tablets FAQs What are INBEC Tablets used for? INBEC Tablets are used as part of antiretroviral treatment for HIV-1 infection in eligible patients. What is the composition of INBEC Tablets? Each tablet contains Abacavir 600 mg + Dolutegravir 50 mg + Lamivudine 300 mg. Can INBEC Tablets cure HIV? No. INBEC helps control HIV by reducing viral replication but does not cure HIV or AIDS. Is INBEC a prescription medicine? Yes. INBEC Tablets are listed as a prescription medicine, so they should be obtained and used under appropriate medical supervision. Can I purchase INBEC Tablets online in India? Availability for online purchase depends on prescription requirements, licensed supply channels and applicable Indian regulations. Cordium Pharmaceuticals Pvt Ltd can assist eligible buyers with product and supply enquiries. How should INBEC Tablets be stored? Follow the storage instructions provided with the product packaging and pharmacist's advice. Current Indian listings indicate storage below 30°C. Can I stop taking INBEC when I feel better? No. HIV treatment should not be stopped or changed without consulting your healthcare professional, as interruption can affect viral control and treatment effectiveness. Medical Disclaimer: This page is for general educational and product-information purposes only and does not replace professional medical advice, diagnosis or treatment. INBEC should be used only under the direction of a qualified healthcare professional.

BDBRUT Capsules Product Description BDBRUT Capsules contain Ibrutinib 140 mg, a targeted cancer medicine belonging to the Bruton’s tyrosine kinase (BTK) inhibitor class. It is a prescription medicine used under the supervision of a qualified oncologist for the management of certain blood cancers and related conditions. BDBRUT Capsules may be prescribed for conditions such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinemia, depending on the patient's diagnosis, treatment history, and the prescribing doctor's assessment. Ibrutinib works by blocking Bruton’s tyrosine kinase (BTK), a protein involved in signaling that helps certain abnormal B cells grow and survive. By interfering with this pathway, the medicine can help control the growth and activity of abnormal cells in specific blood cancers. BDBRUT Capsules Strength and Pack Information Product: BDBRUT Capsules Active ingredient: Ibrutinib Strength: 140 mg Dosage form: Capsule Typical pack: 30 capsules Therapeutic class: Targeted anticancer medicine / BTK inhibitor Prescription status: Prescription medicine BDBRUT Capsules should only be used according to an oncologist's prescription. The appropriate dose and treatment duration depend on the condition being treated, overall health, response to therapy, and other medicines being taken. How to Take BDBRUT Capsules Take BDBRUT Capsules exactly as prescribed by your doctor. The capsule should generally be swallowed whole with water and should not be crushed, opened, or chewed. It may be taken with or without food, according to the prescribed instructions. Do not change the dose or stop treatment without consulting your healthcare professional. Patients may require regular medical monitoring, including blood tests, during treatment. Ibrutinib can affect blood cell counts and may increase the risk of bleeding, infections, high blood pressure, and certain heart rhythm problems. Possible Side Effects Some patients taking BDBRUT may experience diarrhea, nausea, fatigue, headache, fever, rash, muscle or joint pain, bruising, or changes in blood cell counts. Serious reactions can occur, so patients should promptly contact their doctor if they experience unusual bleeding, signs of infection, severe weakness, chest symptoms, or an irregular heartbeat. Inform your doctor about all prescription medicines, over-the-counter products, vitamins, and supplements before starting treatment because some medicines can interact with ibrutinib. Patients should also discuss liver problems, heart conditions, bleeding disorders, pregnancy, or breastfeeding with their doctor. BDBRUT Capsules in India – Cordium Pharmaceuticals Pvt Ltd Cordium Pharmaceuticals Pvt Ltd is a pharmaceutical supplier and exporter from India offering access to a range of medicines for healthcare and pharmaceutical requirements. For enquiries regarding BDBRUT Capsules 140 mg, product availability, pack information, and supply requirements in India, customers can contact Cordium Pharmaceuticals Pvt Ltd for further information. BDBRUT is a prescription medicine, and purchase and use should be handled in accordance with applicable Indian regulations and medical guidance. Frequently Asked Questions 1. What are BDBRUT Capsules used for? BDBRUT Capsules contain ibrutinib 140 mg and may be prescribed for certain blood cancers, including chronic lymphocytic leukemia, small lymphocytic lymphoma, mantle cell lymphoma, and Waldenström’s macroglobulinemia, depending on the patient's medical condition and treatment plan. 2. What is the composition of BDBRUT Capsules? Each BDBRUT Capsule contains Ibrutinib 140 mg as the active ingredient. 3. How does BDBRUT work? Ibrutinib blocks BTK signaling, which is involved in the growth and survival of certain abnormal B cells. This targeted action can help control these cells in specific blood cancers. 4. Can I buy BDBRUT Capsules online in India? BDBRUT is a prescription medicine. Availability and purchase should be through an authorized pharmacy or pharmaceutical supplier and in accordance with applicable regulations. A valid prescription and professional medical guidance may be required. 5. Should I change my BDBRUT dosage if I experience side effects? No. Do not change, skip, or discontinue your prescribed dose without speaking with your treating doctor. Your doctor can determine whether treatment modification or additional monitoring is appropriate. 6. Who should take BDBRUT Capsules? BDBRUT should be taken only by patients for whom a qualified healthcare professional has prescribed ibrutinib based on their diagnosis and individual treatment requirements.